|
Volumn 85, Issue 12, 2008, Pages 1784-1789
|
Initiation of an intestinal transplant program: The indiana experience
|
Author keywords
Intestinal transplantation; Multivisceral transplantation; Transplant outcomes
|
Indexed keywords
ALEMTUZUMAB;
COTRIMOXAZOLE;
CYTOMEGALOVIRUS ANTIBODY;
FLUCONAZOLE;
GANCICLOVIR;
METHYLPREDNISOLONE;
METHYLPREDNISOLONE SODIUM SUCCINATE;
RITUXIMAB;
TACROLIMUS;
THYMOCYTE ANTIBODY;
VALGANCICLOVIR;
ACUTE GRAFT REJECTION;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CHILD;
CLINICAL ARTICLE;
CYTOMEGALOVIRUS INFECTION;
DISEASE SEVERITY;
DRUG BLOOD LEVEL;
DRUG DOSE REDUCTION;
ENTEROPATHY;
FEMALE;
GRAFT RECIPIENT;
GRAFT SURVIVAL;
HEALTH PROGRAM;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFANT;
INTESTINE GRAFT REJECTION;
INTESTINE TRANSPLANTATION;
MALE;
MONOTHERAPY;
MYCOSIS;
OVERALL SURVIVAL;
PEDIATRIC SURGERY;
PNEUMOCYSTIS PNEUMONIA;
POSTOPERATIVE COMPLICATION;
POSTOPERATIVE INFECTION;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
RETRANSPLANTATION;
SCHOOL CHILD;
SINGLE DRUG DOSE;
SURVIVAL RATE;
SURVIVAL TIME;
TREATMENT OUTCOME;
VIRUS INFECTION;
GRAFT REJECTION;
INTESTINE;
KAPLAN MEIER METHOD;
MIDDLE AGED;
ORGAN TRANSPLANTATION;
PROGRAM DEVELOPMENT;
RETROSPECTIVE STUDY;
STATISTICS;
TRANSPLANTATION;
UNITED STATES;
ADOLESCENT;
ADULT;
AGED;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
INDIANA;
INFANT;
INTESTINES;
KAPLAN-MEIERS ESTIMATE;
MALE;
MIDDLE AGED;
ORGAN TRANSPLANTATION;
PROGRAM DEVELOPMENT;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
EID: 49149115036
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/TP.0b013e31817889a1 Document Type: Article |
Times cited : (16)
|
References (8)
|